Противоспаечные барьеры в клинической практике: персонификация менеджмента пациенток

1. Okabayashi K, Ashrafian H, Zacharakis E, et al. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity. Surg Today. 2014;44:405-20. DOI:10.1007/s00595-013-0591-8
2. Coccolini F, Ansaloni L, Manfredi R, et al. Peritoneal adhesion index (PAI): proposal of a score for the “gnored iceberg” of medicine and surgery. World J Emerg Surg. 2013;8(1):6. DOI:10.1186/1749-7922-8-6
3. De Wilde RL, Brölmann H, Koninckx PR, et al. Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecol Surg. 2012;9(4):365-8. DOI:10.1007/s10397-012-0764-2
4. Ray NF, Denton WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998;186(1):1-9.
DOI:10.1016/s1072-7515(97)00127-0
5. Lutsevich OE, Akimov VP, Shirinsky VG, Bichev AA. Adhesive disease of the peritoneum: a modern view of pathogenesis and treatment. Khirurgiia (Mosk). 2017;10:100-8. DOI:10.17116/hirurgia201710100-108
6. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J. 1994;8(11):854-61. DOI:10.1096/fasebj.8.11.7520879
7. Zeyneloglu HB, Senturk LM, Seli E, et al. The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation. Hum Reprod. 1998;13(5):1194-9. DOI:10.1093/humrep/13.5.1194
8. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today. 1991;12(1):17-23. DOI:10.1016/0167-5699(91)90107-5
9. Fernandez H, Benifla JL, Fritel X, et al. Post-curettage and aspiration synechiae: is there value in an anti-adhesion agent? J Gynecol Obstet Biol Reprod (Paris). 2012;41(2):8-12. DOI:10.1016/S0368-2315(12)70004-2
10. Снимщикова И.А., Медведев А.И., Халилов М.А., и др. Теоретические и клинические аспекты избыточного адгезиогенеза. Вестник РГМУ. 2008;4:99-102 [Snimshchikova IA, Medvedev AI, Khalilov MA, et al. Teoreticheskie i klinicheskie aspekty izbytochnogo adgeziogeneza. Vestnik RGMU. 2008;4:99-102 (in Russian)].
11. Oosterlynck DJ, Lacquet FA, Waer M, Koninckx PR. Lymphokinactivated killer activity in women with endometriosis. Gynecol Obstet Invest. 1994;37(3):185-90. DOI:10.1159/000292556
12. Бурлев В.А., Дубинская Е.Д., Гаспаров А.С., Ильясова Н.А. Антиангиогенная терапия и спаечный процесс в малом тазу: перспективы профилактики и лечения. Российский вестник акушера-гинеколога. 2010;10(4):25-31 [Burlev VA, Dubinskaia ED, Gasparov AS, Il'iasova NA. Antiangiogenic therapy and a commissural process in the small pelvis: prospects for prevention and treatment. Russian Bulletin of Obstetrician-Gynecologist. 2010;10(4):25-31 (in Russian)].
13. Tabibian N, Swehli E, Boyd A, et al. Abdominal adhesions: A practical review of an often overlooked entity. Ann Med Surg (Lond). 2017;15:9-13. DOI:10.1016/j.amsu.2017.01.021
14. Sabry D, Mostafa A, Mekawey D, et al. An experimental model: intrauterine adhesion versus subendometrial fibrosis. Biomedical Research. 2018;29(17):3311-8. DOI:10.4066/biomedicalresearch.29-18-849
15. Fritsch H. Ein Fall von volligen Schwund der Gebaumutterhohle nach Auskratzung. Zentralbl Gynaekol. 1894;18:1337-42. 
16. Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1948;57(6):892-6. DOI:10.1111/j.1471-0528.1950.tb06053.x
17. Yu D, Wong YM, Cheong Y, et al. Asherman syndrome – one century later. Fertil Steril. 2008;89:759-79. DOI:10.1016/j.fertnstert.2008.02.096 
18. Lin S, Xie X, Guo Y, et al. Clinical characteristics and pregnancy outcomes of infertile patients with endometriosis and endometrial polyps: 
A retrospective cohort study. Taiwan J Obstet Gynecol. 2020;59:916-21. DOI:10.1016/j.tjog.2020.09.020
19. Owusu-Akyaw A, Krishnamoorthy K, Goldsmith LT, Morelli SS. The role of mesenchymal-epithelial transition in endometrial function. Hum Reprod Update. 2019;25:114-33. DOI:10.1093/humupd/dmy035
20. March CM. Asherman's syndrome. Semin Reprod Med. 2011;29(2):83-94. DOI:10.1055/s-0031-1272470
21. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9(1):283-9. DOI:10.2741/1184
22. Chen JX, Yi XJ, Gu PL, Gao SX. The role of KDR in intrauterine adhesions may involve the TGF-β1/Smads signaling pathway. Braz J Med Biol Res. 2019;52(10):e8324. DOI:10.1590/1414-431X20198324
23. Li J, Cen B, Chen S, He Y. MicroRNA-29b inhibits TGF-β1-induced fibrosis via regulation of the TGF-β1/Smad pathway in primary human endometrial stromal cells. Mol Med Rep. 2016;13(5):4229-37. DOI:10.3892/mmr.2016.5062
24. Van Beek JP, Kennedy L, Rockel JS, et al. The induction of CCN2 by TGFβ1 involves Ets-1. Arthritis Res Ther. 2006;8(2):R36. DOI:10.1186/ar1890
25. Evans J, Salamonsen LA, Winship A, et al. Fertile ground: Human endometrial programming and lessons in health and disease. Nat Rev Endocrinol. 2016;12:654-67. DOI:10.1038/nrendo.2016.116
26. Zhou Q, Shi X, Saravelos S, et al. Auto-cross-linked hyaluronic acid gel for prevention of intrauterine adhesions after hysteroscopic adhesiolysis: 
A randomized controlled trial. J Minim Invasive Gynecol. 2021:28;307-13. DOI:10.1016/j.jmig.2020.06.030
27. Lin X, Wei M, Li TC, et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: A cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;170:512-6. DOI:10.1016/j.ejogrb.2013.07.018
28. Zhu R, Duan H, Gan L, Wang S. Comparison of Intrauterine Suitable Balloon and Foley Balloon in the Prevention of Adhesion after Hysteroscopic Adhesiolysis. Biomed Res Int. 2018;2018:9494101. DOI:10.1155/2018/9494101 
29. Lee WL, Lee FK, Wang PH. Application of hyaluronic acid in patients with interstitial cystitis. J Chin Med Assoc. 2021;84:341-3. 
DOI:10.1097/JCMA.0000000000000489
30. Friedman JA, Wong JMK, Chaudhari A, et al. Hysteroscopic myomectomy: A comparison of techniques and review of current evidence in the management of abnormal uterine bleeding. Curr Opin Obstet Gynecol. 2018;30:243-51. DOI:10.1097/GCO.0000000000000475
31. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFb activation. J Cell Sci. 2003;116(2):217-24. DOI:10.1242/jcs.00229
32. Kim T, Ahn KH, Choi DS, et al. A randomized, multi-center, clinical trial to assess the efficacy and safety of alginate carboxymethylcellulose hyaluronic acid compared to carboxymethylcellulose hyaluronic acid to prevent postoperative intrauterine adhesion. J Minim Invasive Gynecol. 2012;19:731-6. DOI:10.1016/j.jmig.2012.08.003

________________________________________________

1. Okabayashi K, Ashrafian H, Zacharakis E, et al. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity. Surg Today. 2014;44:405-20. DOI:10.1007/s00595-013-0591-8
2. Coccolini F, Ansaloni L, Manfredi R, et al. Peritoneal adhesion index (PAI): proposal of a score for the “gnored iceberg” of medicine and surgery. World J Emerg Surg. 2013;8(1):6. DOI:10.1186/1749-7922-8-6
3. De Wilde RL, Brölmann H, Koninckx PR, et al. Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecol Surg. 2012;9(4):365-8. DOI:10.1007/s10397-012-0764-2
4. Ray NF, Denton WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998;186(1):1-9.
DOI:10.1016/s1072-7515(97)00127-0
5. Lutsevich OE, Akimov VP, Shirinsky VG, Bichev AA. Adhesive disease of the peritoneum: a modern view of pathogenesis and treatment. Khirurgiia (Mosk). 2017;10:100-8. DOI:10.17116/hirurgia201710100-108
6. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J. 1994;8(11):854-61. DOI:10.1096/fasebj.8.11.7520879
7. Zeyneloglu HB, Senturk LM, Seli E, et al. The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation. Hum Reprod. 1998;13(5):1194-9. DOI:10.1093/humrep/13.5.1194
8. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today. 1991;12(1):17-23. DOI:10.1016/0167-5699(91)90107-5
9. Fernandez H, Benifla JL, Fritel X, et al. Post-curettage and aspiration synechiae: is there value in an anti-adhesion agent? J Gynecol Obstet Biol Reprod (Paris). 2012;41(2):8-12. DOI:10.1016/S0368-2315(12)70004-2
10. Snimshchikova IA, Medvedev AI, Khalilov MA, et al. Teoreticheskie i klinicheskie aspekty izbytochnogo adgeziogeneza. Vestnik RGMU. 2008;4:99-102 (in Russian).
11. Oosterlynck DJ, Lacquet FA, Waer M, Koninckx PR. Lymphokinactivated killer activity in women with endometriosis. Gynecol Obstet Invest. 1994;37(3):185-90. DOI:10.1159/000292556
12. Burlev VA, Dubinskaia ED, Gasparov AS, Il'iasova NA. Antiangiogenic therapy and a commissural process in the small pelvis: prospects for prevention and treatment. Russian Bulletin of Obstetrician-Gynecologist. 2010;10(4):25-31 (in Russian).
13. Tabibian N, Swehli E, Boyd A, et al. Abdominal adhesions: A practical review of an often overlooked entity. Ann Med Surg (Lond). 2017;15:9-13. DOI:10.1016/j.amsu.2017.01.021
14. Sabry D, Mostafa A, Mekawey D, et al. An experimental model: intrauterine adhesion versus subendometrial fibrosis. Biomedical Research. 2018;29(17):3311-8. DOI:10.4066/biomedicalresearch.29-18-849
15. Fritsch H. Ein Fall von volligen Schwund der Gebaumutterhohle nach Auskratzung. Zentralbl Gynaekol. 1894;18:1337-42. 
16. Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1948;57(6):892-6. DOI:10.1111/j.1471-0528.1950.tb06053.x
17. Yu D, Wong YM, Cheong Y, et al. Asherman syndrome – one century later. Fertil Steril. 2008;89:759-79. DOI:10.1016/j.fertnstert.2008.02.096 
18. Lin S, Xie X, Guo Y, et al. Clinical characteristics and pregnancy outcomes of infertile patients with endometriosis and endometrial polyps: 
A retrospective cohort study. Taiwan J Obstet Gynecol. 2020;59:916-21. DOI:10.1016/j.tjog.2020.09.020
19. Owusu-Akyaw A, Krishnamoorthy K, Goldsmith LT, Morelli SS. The role of mesenchymal-epithelial transition in endometrial function. Hum Reprod Update. 2019;25:114-33. DOI:10.1093/humupd/dmy035
20. March CM. Asherman's syndrome. Semin Reprod Med. 2011;29(2):83-94. DOI:10.1055/s-0031-1272470
21. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9(1):283-9. DOI:10.2741/1184
22. Chen JX, Yi XJ, Gu PL, Gao SX. The role of KDR in intrauterine adhesions may involve the TGF-β1/Smads signaling pathway. Braz J Med Biol Res. 2019;52(10):e8324. DOI:10.1590/1414-431X20198324
23. Li J, Cen B, Chen S, He Y. MicroRNA-29b inhibits TGF-β1-induced fibrosis via regulation of the TGF-β1/Smad pathway in primary human endometrial stromal cells. Mol Med Rep. 2016;13(5):4229-37. DOI:10.3892/mmr.2016.5062
24. Van Beek JP, Kennedy L, Rockel JS, et al. The induction of CCN2 by TGFβ1 involves Ets-1. Arthritis Res Ther. 2006;8(2):R36. DOI:10.1186/ar1890
25. Evans J, Salamonsen LA, Winship A, et al. Fertile ground: Human endometrial programming and lessons in health and disease. Nat Rev Endocrinol. 2016;12:654-67. DOI:10.1038/nrendo.2016.116
26. Zhou Q, Shi X, Saravelos S, et al. Auto-cross-linked hyaluronic acid gel for prevention of intrauterine adhesions after hysteroscopic adhesiolysis: 
A randomized controlled trial. J Minim Invasive Gynecol. 2021:28;307-13. DOI:10.1016/j.jmig.2020.06.030
27. Lin X, Wei M, Li TC, et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: A cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;170:512-6. DOI:10.1016/j.ejogrb.2013.07.018
28. Zhu R, Duan H, Gan L, Wang S. Comparison of Intrauterine Suitable Balloon and Foley Balloon in the Prevention of Adhesion after Hysteroscopic Adhesiolysis. Biomed Res Int. 2018;2018:9494101. DOI:10.1155/2018/9494101 
29. Lee WL, Lee FK, Wang PH. Application of hyaluronic acid in patients with interstitial cystitis. J Chin Med Assoc. 2021;84:341-3. 
DOI:10.1097/JCMA.0000000000000489
30. Friedman JA, Wong JMK, Chaudhari A, et al. Hysteroscopic myomectomy: A comparison of techniques and review of current evidence in the management of abnormal uterine bleeding. Curr Opin Obstet Gynecol. 2018;30:243-51. DOI:10.1097/GCO.0000000000000475
31. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFb activation. J Cell Sci. 2003;116(2):217-24. DOI:10.1242/jcs.00229
32. Kim T, Ahn KH, Choi DS, et al. A randomized, multi-center, clinical trial to assess the efficacy and safety of alginate carboxymethylcellulose hyaluronic acid compared to carboxymethylcellulose hyaluronic acid to prevent postoperative intrauterine adhesion. J Minim Invasive Gynecol. 2012;19:731-6. DOI:10.1016/j.jmig.2012.08.003

М.Р. Оразов*1, В.Е. Радзинский1, М.Б. Хамошина1, Л.М. Михалева2, С.Я. Исмаилзаде1

1 ФГАОУ ВО «Российский университет дружбы народов», Москва, Россия;
2 ФГБНУ «Научно-исследовательский институт морфологии человека им. акад. А.П. Авцына», Москва, Россия
*omekan@mail.ru

________________________________________________

Mekan R. Orazov*1, Viktor E. Radzinsky1, Marina B. Khamoshina1, Liudmila M. Mikhaleva2, Sevinc Ya. Ismailzade1

1 People’s Friendship University of Russia (RUDN University), Moscow, Russia;
2 Avtsyn Research Institute of Human Morphology, Moscow, Russia
*omekan@mail.ru